CD300LD: A Drug Target / Disease Biomarker (G100131439)

CD300LD: A Drug Target / Disease Biomarker

CD300LD is a protein that is expressed in a variety of tissues throughout the body, including the skin, lungs, heart, and brain. It is a member of the immunoglobulin superfamily and is involved in the development and maintenance of immune responses. CD300LD has also been shown to play a role in cancer progression and has potential as a drug target or biomarker.

CD300LD is a 21-kDa protein that is expressed in a variety of tissues throughout the body. It is found in the skin, lung, heart, and brain, among other tissues. CD300LD is a member of the immunoglobulin superfamily and is composed of four constant (C) regions and one variable (V) region. The C regions give CD300LD its characteristic monomeric structure, while the V region contains the variable regions that are unique to each individual protein.

CD300LD is involved in the development and maintenance of immune responses. It is a key regulator of the T cell response, specifically of the development and function of T cells. T cells are a critical component of the immune system and play a crucial role in protecting the body against infection and disease. CD300LD has been shown to regulate the growth, survival, and differentiation of T cells, as well as the production of antibodies.

In addition to its role in T cell development, CD300LD has also been shown to be involved in cancer progression. Many studies have shown that CD300LD is highly expressed in various types of cancer, including breast, ovarian, and colorectal cancers. It has also been shown to be associated with poor prognosis in patients with these cancers.

CD300LD has also been shown to have potential as a drug target or biomarker. One way to target CD300LD is through the use of small molecules that can inhibit its activity. For example, researchers have shown that inhibitors of CD300LD can be effective in treating breast cancer by inhibiting its ability to promote the growth and survival of cancer cells.

Another way to use CD300LD as a biomarker is through the use of antibodies that recognize specific regions of the protein. These antibodies can be used to diagnose or monitor the progression of cancer. For example, researchers have shown that antibodies against CD300LD can be used to detect breast cancer in primary cultures of breast tissue.

In conclusion, CD300LD is a protein that is expressed in a variety of tissues throughout the body and is involved in the development and maintenance of immune responses. It has also been shown to play a role in cancer progression and has potential as a drug target or biomarker. Further research is needed to fully understand the role of CD300LD in these processes and to develop effective treatments.

Protein Name: CD300 Molecule Like Family Member D

The "CD300LD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CD300LD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CD300LD-AS1 | CD300LF | CD300LG | CD302 | CD320 | CD33 | CD34 | CD36 | CD37 | CD38 | CD3D | CD3E | CD3G | CD4 | CD40 | CD40LG | CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70 | CD72 | CD74 | CD79A | CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2 | CD9 | CD93 | CD96 | CD99 | CD99L2 | CD99P1 | CDA | CDADC1 | CDAN1 | CDC123 | CDC14A | CDC14B | CDC14C | CDC16 | CDC20 | CDC20-DT | CDC20B | CDC20P1 | CDC23 | CDC25A | CDC25B | CDC25C | CDC26 | CDC27 | CDC27P2 | CDC34 | CDC37 | CDC37L1 | CDC37P1 | CDC40 | CDC42 | CDC42BPA | CDC42BPB | CDC42BPG | CDC42EP1 | CDC42EP2 | CDC42EP3 | CDC42EP4 | CDC42EP5 | CDC42SE1 | CDC42SE2 | CDC45 | CDC5L | CDC5L complex | CDC6 | CDC7 | CDC73 | CDCA2 | CDCA3 | CDCA4 | CDCA4P3